# Use of Ranibizumab With Mitomycin C During Trabeculectomy

> **NCT00661583** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 30 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Ranibizumab
- **DRUG:** Ranibizumab and MMC
- **DRUG:** MMC

## Key facts

- **NCT ID:** NCT00661583
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00661583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00661583, "Use of Ranibizumab With Mitomycin C During Trabeculectomy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00661583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*